Australian pharmaceutical company LTR Pharma has begun recruiting subjects in a bioequivalence clinical study of SPONTAN, a quick-acting nasal spray designed to treat erectile dysfunction (ED).

Manufacturers of impotence pills are facing a new challenge in the form of a nasal spray that acts ... and administers apomorphine to help erectile dysfunction. Because the drug is breathed ...

Students requested the vending machine with Narcan to be proactive and responsive to the city's opioid crisis, Penn officials ...

Originally published as ASX Quarterly Health Wrap: Lift-off for ED nasal spray and record users for pregnancy-monitoring platform ...

The APS enables registered medical practitioners to prescribe Spontan to a broader class of patients with ED, streamlining access ... Aptar Pharma's expertise in nasal spray technology.